TY - JOUR
T1 - Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease
AU - Keio COPD Comorbidity Research Group
AU - Chubachi, Shotaro
AU - Takahashi, Saeko
AU - Tsutsumi, Akihiro
AU - Kameyama, Naofumi
AU - Sasaki, Mamoru
AU - Naoki, Katsuhiko
AU - Soejima, Kenzo
AU - Nakamura, Hidetoshi
AU - Asano, Koichiro
AU - Betsuyaku, Tomoko
N1 - Funding Information:
The authors acknowledge Masahiro Jinzaki of the Department of Diagnostic Radiology, Keio University School of Medicine, and Tamami Nakajima of AZE for helping in the analysis of chest CT imaging findings and in calibrating the CT instruments; Chiyomi Uemura for helping with data collection; and Hidehiro Irie for helping with data collection and interpretation of data. The authors also acknowledge all the members of the Keio COPD Comorbidity Research Group who participated in this study, including Saiseikai Utsunomiya Hospital, Eiju General Hospital, Tokyo Saiseikai Central Hospital, Sano Public Welfare General Hospital, Nihon Kokan Hospital, Saitama Social Insurance Hospital, Kawasaki City Ida Hospital, Saitama City Hospital, Tokyo Medical Center, Tokyo Dental College Ichikawa General Hospital, Tokyo Electric Power Company Hospital, and the International Medical Welfare College Shioya Hospital.
Publisher Copyright:
© 2017 Chubachi et al.
PY - 2017/5/30
Y1 - 2017/5/30
N2 - Background: Only a few studies have evaluated the radiologic features of pre-existing structural abnormalities where lung cancer may develop. This study aimed to analyze the computed tomography (CT) images of lung areas where new cancer developed in chronic obstructive pulmonary disease (COPD) patients. Patients and methods: We conducted a multicenter, longitudinal cohort study, called the Keio COPD Comorbidity Research, to assess the incidence of lung cancer. Emphysema and interstitial abnormalities were evaluated in 240 COPD patients who had baseline CT scans applicable for further digital analyses. For patients who developed lung cancer during the 3-year follow-up period, the local spherical lung density of the precancerous area was individually quantified. Results: Lung cancer was newly diagnosed in 21 participants (2.3% per year). The percentage of low attenuation area in patients who developed lung cancer was higher than that of the other patients (20.0% vs 10.4%, P=0.014). The presence of emphysema (odds ratio [OR] 4.2, 95% confidence interval [CI] 1.0–29.0, P=0.049) or interstitial lung abnormalities (OR 15.6, 95% CI 4.4–65.4, P<0.0001) independently increased the risk for lung cancer. Compared with the density of the entire lung, the local density of the precancerous area was almost the same in patients with heterogeneous emphysema, but it was higher in most patients with interstitial abnormalities. Conclusion: The presence of emphysema or interstitial abnormalities or a combination of both were independent predictors of lung cancer development in COPD patients. Furthermore, lung cancer most often developed in non-emphysematous areas or in interstitial abnormalities.
AB - Background: Only a few studies have evaluated the radiologic features of pre-existing structural abnormalities where lung cancer may develop. This study aimed to analyze the computed tomography (CT) images of lung areas where new cancer developed in chronic obstructive pulmonary disease (COPD) patients. Patients and methods: We conducted a multicenter, longitudinal cohort study, called the Keio COPD Comorbidity Research, to assess the incidence of lung cancer. Emphysema and interstitial abnormalities were evaluated in 240 COPD patients who had baseline CT scans applicable for further digital analyses. For patients who developed lung cancer during the 3-year follow-up period, the local spherical lung density of the precancerous area was individually quantified. Results: Lung cancer was newly diagnosed in 21 participants (2.3% per year). The percentage of low attenuation area in patients who developed lung cancer was higher than that of the other patients (20.0% vs 10.4%, P=0.014). The presence of emphysema (odds ratio [OR] 4.2, 95% confidence interval [CI] 1.0–29.0, P=0.049) or interstitial lung abnormalities (OR 15.6, 95% CI 4.4–65.4, P<0.0001) independently increased the risk for lung cancer. Compared with the density of the entire lung, the local density of the precancerous area was almost the same in patients with heterogeneous emphysema, but it was higher in most patients with interstitial abnormalities. Conclusion: The presence of emphysema or interstitial abnormalities or a combination of both were independent predictors of lung cancer development in COPD patients. Furthermore, lung cancer most often developed in non-emphysematous areas or in interstitial abnormalities.
KW - COPD
KW - Computed tomography
KW - Emphysema
KW - Interstitial lung disease
KW - Lung cancer
UR - http://www.scopus.com/inward/record.url?scp=85020420227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020420227&partnerID=8YFLogxK
U2 - 10.2147/COPD.S132709
DO - 10.2147/COPD.S132709
M3 - Article
C2 - 28615934
AN - SCOPUS:85020420227
SN - 1176-9106
VL - 12
SP - 1613
EP - 1624
JO - International Journal of COPD
JF - International Journal of COPD
ER -